Variant report
Variant | nsv4264 |
---|---|
Chromosome Location | chr4:21138131-21199262 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:21159106..21161937-chr4:21165905..21168685,2 | MCF-7 | breast: | |
2 | chr4:21186540..21187139-chr4:21470730..21471606,2 | MCF-7 | breast: | |
3 | chr4:21186139..21187069-chr4:21470759..21471732,3 | MCF-7 | breast: | |
4 | chr4:21159106..21161937-chr4:21165905..21168685,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16870439 | chr4:21138156-21138157 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs56052027 | chr4:21138192-21138193 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs191221060 | chr4:21138193-21138194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547882402 | chr4:21138219-21138220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183726874 | chr4:21138264-21138265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188262187 | chr4:21138286-21138287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370224667 | chr4:21138299-21138300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34878637 | chr4:21138305-21138306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1433483 | chr4:21138339-21138340 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs570003931 | chr4:21138362-21138363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537394950 | chr4:21138374-21138375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386672387 | chr4:21138382-21138383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1433482 | chr4:21138383-21138384 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs145161519 | chr4:21138410-21138411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192791527 | chr4:21138428-21138429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73805017 | chr4:21138431-21138432 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs142302220 | chr4:21138457-21138458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574883983 | chr4:21138471-21138472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563523933 | chr4:21138479-21138480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530781567 | chr4:21138528-21138529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185127647 | chr4:21138535-21138536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146819751 | chr4:21138536-21138537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529307967 | chr4:21138628-21138629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190009243 | chr4:21138675-21138676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566149960 | chr4:21138699-21138700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181814877 | chr4:21138707-21138708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11360206 | chr4:21138732-21138733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551555947 | chr4:21138738-21138739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73107431 | chr4:21138749-21138750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537314988 | chr4:21138763-21138764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538045700 | chr4:21152082-21152083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545934791 | chr4:21152118-21152119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145532822 | chr4:21152132-21152133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576254933 | chr4:21152167-21152168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557970420 | chr4:21152173-21152174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577869091 | chr4:21152188-21152189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543764771 | chr4:21152215-21152216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561994474 | chr4:21152216-21152217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191617063 | chr4:21152225-21152226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540546631 | chr4:21152366-21152367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548644120 | chr4:21152374-21152375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140338315 | chr4:21152390-21152391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527787704 | chr4:21152409-21152410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377472686 | chr4:21152410-21152411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6854413 | chr4:21152422-21152423 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs113506265 | chr4:21152470-21152471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538076518 | chr4:21152485-21152486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550045480 | chr4:21152499-21152500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573936494 | chr4:21152617-21152618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552336108 | chr4:21152633-21152634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 22737080 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Cancer | 22183965 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:21137000-21138800 | Enhancers | HUVEC | blood vessel |
2 | chr4:21152000-21153600 | Enhancers | HepG2 | liver |
3 | chr4:21160800-21161200 | Active TSS | HUES6 Cell Line | embryonic stem cell |
4 | chr4:21166400-21169800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr4:21175200-21175800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr4:21175200-21176000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr4:21177000-21179200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr4:21181400-21181600 | Enhancers | Fetal Lung | lung |
9 | chr4:21181600-21182600 | Weak transcription | Fetal Lung | lung |
10 | chr4:21182600-21183800 | Enhancers | Fetal Lung | lung |
11 | chr4:21185400-21186400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr4:21186000-21186600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr4:21186400-21187800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr4:21187800-21188000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr4:21189000-21189400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr4:21189200-21192400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
17 | chr4:21192400-21192800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr4:21192400-21193400 | Enhancers | Fetal Brain Female | brain |
19 | chr4:21192400-21193600 | Enhancers | Brain Germinal Matrix | brain |
20 | chr4:21193600-21194800 | Weak transcription | Brain Germinal Matrix | brain |
21 | chr4:21194800-21195200 | Enhancers | Brain Germinal Matrix | brain |